Improving HIV vaccine effectiveness by blocking immune suppression
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy
This study is looking at ways to make HIV vaccines work better by figuring out how certain immune cells, called natural killer cells, can sometimes hold back the body's immune response, and it’s for anyone interested in improving HIV vaccine effectiveness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11014411 on NIH RePORTER |
What this research studies
This research investigates how to enhance the effectiveness of HIV vaccines by addressing the immune suppression caused by natural killer (NK) cells. The study aims to understand the mechanisms by which NK cells inhibit the immune response, particularly the production of neutralizing antibodies and the activation of T cells. By developing strategies to block this suppression, the research seeks to improve the quality and quantity of immune responses triggered by vaccines, ultimately aiming to create a more effective HIV vaccine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection who may benefit from improved vaccination strategies.
Not a fit: Patients who are already living with HIV and are not seeking vaccination may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a more effective HIV vaccine, significantly reducing new infections.
How similar studies have performed: Other research has shown promise in enhancing vaccine responses by targeting immune suppression, suggesting that this approach could be effective.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Waggoner, Stephen N. — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Waggoner, Stephen N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.